Vivace Therapeutics Company Profile 2024: Valuation, Funding ...

The company is built on innovative science in novel pathways and leverages research from leading academic laboratories by developing therapeutics that could work alone or in …

CouponFollow Extension

$70
OFF

Vivace Therapeutics - Company Profile - Tracxn

6 days from now

Nov 16, 2024 · Vivace Therapeutics - Developer of cancer therapeutics targeting a novel cancer pathway. Raised a total funding of $70M over 3 rounds from 9 investors. Vivace Therapeutics …

tracxn.com

$30
OFF

Vivace Therapeutics Company Profile: Overview And Full News …

6 days from now

Vivace Therapeutics has raised another $30 million to pursue drugs targeting the Hippo-YAP pathway . The funding will push its lead program into the clinic in the first half of 2021 . It …

ourcrowd.com

$70
OFF

Vivace Therapeutics Stock Price, Funding, Valuation, Revenue ...

6 days from now

Dec 16, 2020 · Funding, Valuation & Revenue. 3 Fundings. Vivace Therapeutics has raised $70M over 3 rounds.. Vivace Therapeutics's latest funding round was a Series C for $30M on …

cbinsights.com

$70
OFF

Vivace Therapeutics Company Profile - Office Locations ... - Craft

6 days from now

Vivace Therapeutics has 5 employees at their 1 location and $70 m in total funding,. See insights on Vivace Therapeutics including office locations, competitors, revenue, financials, executives, …

craft.co

FAQs about Vivace Therapeutics Company Profile 2024: Valuation, Funding ... Coupon?

Who is Vivace Therapeutics?

Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway. At Vivace Therapeutics, they pursue their work with passion, driven by a conviction to help people fight cancer and live life to the fullest. Where is Vivace Therapeutics's headquarters? ...

How many investors does Vivace Therapeutics have?

Vivace Therapeutics has 8 investors including Boxer Capital and Canaan Partners. How much funding has Vivace Therapeutics raised to date? Vivace Therapeutics has raised ...

When did Vivace Therapeutics close?

Vivace Therapeutics closed its last funding round on Dec 16, 2020 from a Series C round. Who are Vivace Therapeutics's competitors? Alternatives and possible competitors to Vivace Therapeutics may include Scholar Rock , Semma Therapeutics , and Proteostasis Therapeutics. ...

When was the last funding round for Vivace Therapeutics?

Vivace Therapeutics closed its last funding round on Dec 16, 2020 from a Series C round. Who are Vivace Therapeutics's competitors? ...

What are alternatives to Vivace Therapeutics?

Alternatives and possible competitors to Vivace Therapeutics may include Scholar Rock , Semma Therapeutics , and Proteostasis Therapeutics. Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway. ...

How much money has Vivan Therapeutics raised?

The current revenue for Vivan Therapeutics is . How much funding has Vivan Therapeutics raised over time? Vivan Therapeutics has raised $3.65M. Who are Vivan Therapeutics’s investors? Reflect Ventures, Voyagers.io, European Innovation Council Fund, Innovate UK, and Granatus Ventures are 5 of 8 investors who have invested in Vivan Therapeutics. ...